Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

In a previous study, we identified somatic mutations of SF3B1, a gene encoding a core component of RNA splicing machinery, in patients with myelodysplastic syndrome (MDS). Here, we define the clinical significance of these mutations in MDS and myelodysplastic/myeloproliferative neoplasms (MDS/MPN)....

Podrobná bibliografie
Hlavní autoři:	Malcovati, L, Papaemmanuil, E, Bowen, D, Boultwood, J, Della Porta, MG, Pascutto, C, Travaglino, E, Groves, M, Godfrey, A, Ambaglio, I, Gallì, A, Vià, D, Conte, S, Tauro, S, Keenan, N, Hyslop, A, Hinton, J, Mudie, L, Wainscoat, J, Futreal, P, Stratton, MR, Campbell, P, Hellström-Lindberg, E, Cazzola, M
Médium:	Journal article
Jazyk:	English
Vydáno:	2011

Podobné jednotky

Myelodysplastic/myeloproliferative disorders
Autor: Luca Malcovati, a další
Vydáno: (2008-01-01)

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
Autor: Luca Malcovati, a další
Vydáno: (2014-11-01)

Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Autor: Mario Cazzola
Vydáno: (2011-03-01)

Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool
Autor: Matteo G. Della Porta, a další
Vydáno: (2012-04-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2009)

Clonality in the myelodysplastic syndromes.
Autor: Boultwood, J, a další
Vydáno: (2001)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
Autor: Malcovati, L, a další
Vydáno: (2011)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Autor: Pellagatti, A, a další
Vydáno: (2010)

Molecular basis of myelodysplastic/myeloproliferative neoplasms
Autor: Andreas Reiter, a další
Vydáno: (2009-12-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2010)

Molecular pathogenesis of the myelodysplastic syndromes
Autor: Boultwood, J, a další
Vydáno: (1999)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
Autor: Pellagatti, A, a další
Vydáno: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
Autor: Pellagatti, A, a další
Vydáno: (2011)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
Autor: Zhang, J, a další
Vydáno: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Autor: Pellagatti, A, a další
Vydáno: (2008)

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
Autor: Matteo G. Della Porta, a další
Vydáno: (2011-03-01)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Autor: Papaemmanuil, E, a další
Vydáno: (2013)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
Autor: I. N. Subortseva, a další
Vydáno: (2017-01-01)

Telomere length in myelodysplastic syndromes.
Autor: Boultwood, J, a další
Vydáno: (1995)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Autor: Pellagatti, A, a další
Vydáno: (2009)

Myelodysplastic syndromes
Autor: Eva Hellström Lindberg
Vydáno: (2018-06-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2010)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
Autor: Boultwood, J, a další
Vydáno: (2009)

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
Autor: Luca Malcovati, a další
Vydáno: (2011-10-01)

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic
Autor: Papaemmanuil, E, a další
Vydáno: (2012)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
Autor: Pellagatti, A, a další
Vydáno: (2017)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Autor: Pellagatti, A, a další
Vydáno: (2013)

Gene expression profiling in the myelodysplastic syndromes.
Autor: Pellagatti, A, a další
Vydáno: (2005)

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
Autor: Ilaria Ambaglio, a další
Vydáno: (2013-03-01)

Genome sequencing in the management of myelodysplastic syndromes and related disorders
Autor: Mario Cazzola, a další
Vydáno: (2024-10-01)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
Autor: Boultwood, J, a další
Vydáno: (1991)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Autor: Pellagatti, A, a další
Vydáno: (2014)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Autor: Boultwood, J, a další
Vydáno: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
Autor: Pellagatti, A, a další
Vydáno: (2007)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
Autor: Ziqi Wan, a další
Vydáno: (2020-10-01)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
Autor: Pellagatti, A, a další
Vydáno: (2005)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
Autor: Wang, L, a další
Vydáno: (2007)

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms
Autor: Michael J. Hochman, a další
Vydáno: (2021-08-01)

Myelodysplastic and myeloproliferative diseases in children: current concepts
Autor: Vyas, P
Vydáno: (2014)